拮抗剂-话题@MedSci

#拮抗剂#

223篇内容 | 4263人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1511601, encodeId=5627151160183, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=钙拮抗剂为基础的联合降压效优, objectType=article, longId=5576, objectId=1eb655e6f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1eb655e6f3, replyNumber=0, likeNumber=0, createdTime=2012-04-22, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1eb655e6f3, moduleTitle=钙拮抗剂为基础的联合降压效优, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1eb655e6f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511600, encodeId=56a8151160065, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=日本大冢公司血管加压素受体拮抗剂托伐普坦（苏麦卡）在中国上市, objectType=article, longId=4134, objectId=c16b4134b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c16b4134b8, replyNumber=0, likeNumber=76, createdTime=2012-02-26, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c16b4134b8, moduleTitle=日本大冢公司血管加压素受体拮抗剂托伐普坦（苏麦卡）在中国上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c16b4134b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511599, encodeId=c809151159936, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=一名肝硬化患者接受血管紧张素转换酶抑制剂/血管紧张素II 受体拮抗剂联合疗法后发生重度肝性脑病：病例报告, objectType=article, longId=2673, objectId=404026e3da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=404026e3da, replyNumber=0, likeNumber=79, createdTime=2011-06-09, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=404026e3da, moduleTitle=一名肝硬化患者接受血管紧张素转换酶抑制剂/血管紧张素II 受体拮抗剂联合疗法后发生重度肝性脑病：病例报告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=404026e3da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511598, encodeId=e03715115980a, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Rolofylline（一种腺苷A1受体拮抗剂）对急性心衰作用无效, objectType=article, longId=2202, objectId=516e2202b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=516e2202b0, replyNumber=0, likeNumber=69, createdTime=2010-10-19, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=516e2202b0, moduleTitle=Rolofylline（一种腺苷A1受体拮抗剂）对急性心衰作用无效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=516e2202b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

拮抗剂

2020-05-29

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

钙拮抗剂为基础的联合降压效优

2012-04-22

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

日本大冢公司血管加压素受体拮抗剂托伐普坦（苏麦卡）在中国上市

2012-02-26

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

一名肝硬化患者接受血管紧张素转换酶抑制剂/血管紧张素II 受体拮抗剂联合疗法后发生重度肝性脑病：病例报告

2011-06-09

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Rolofylline（一种腺苷A1受体拮抗剂）对急性心衰作用无效

2010-10-19

科室
- - 订阅+
  - 更多科室
工具
服务